Novartis Kisqali Dosepak and Lilly Verzenio Dosepak, both developed to aid patients with metastatic breast cancer, tied for the Compliance Package of the Year award in the Healthcare Compliance Packaging Council (HCPC)’s 2017 annual competition.
Novartis Kisqali Dosepak
Kisqali requires three pills a day to be taken at the same time, each day for three weeks. Patient adherence to this regimen is extremely important. This award-winning medication package promotes patient adherence by implementing a custom design.
Lilly Verzenio Dosepak
Lilly’s Verzenio requires the patient to take both a morning and evening dose. Its packaging promotes patient medication adherence using a custom design.
SOURCE: Healthcare Packaging